Skip to content
OpenCapital
Get started

AtriCure ATRC Cash Provided by (Used in) Operating Activity, Including Discontinued Operation

Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies

Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
-$14.6M-7.9%
Avanos Medical logo
Avanos MedicalAVNS
-$12.3M-148%
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-9.9%
Enterprise value$1.36B-13.1%
P/S2.6×-0.7×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%—

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's cash provided by (used in) operating activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's cash provided by (used in) operating activity, including discontinued operation?
AtriCure (ATRC) reported cash provided by (used in) operating activity, including discontinued operation of -$4M in Q1 2026.
How has AtriCure's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
AtriCure's cash provided by (used in) operating activity, including discontinued operation increased by 63.8% year-over-year, from -$11.03M to -$4M.
What is the long-term trend for AtriCure's cash provided by (used in) operating activity, including discontinued operation?
Over 3 years (2021 to 2025), AtriCure's cash provided by (used in) operating activity, including discontinued operation has grown at a 59.7% compound annual growth rate (CAGR), from -$14.08M to $57.33M.
What does cash provided by (used in) operating activity, including discontinued operation mean?
Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.